1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25 | Licensing Program Analyst (LPA) Elizabeth Irra conducted an initial complaint investigation visit and met with Ana Rempel (Administrator) and Zara Poghosyan (Director).
During this complaint visit, it was discovered that R-1’s records were incomplete. LPA discovered multiple staff initials missing on R-1’s Medication Administration Record (MAR) for the January 2025 log. The MAR was missing initials for the following medications: Triamcinolone, Aripiprazole, Lorazapam/Avitan, Fluocinonide, Ammonium Lactate, Citalopram, Lisinopril, Atorvastatin, Metformin HCI, Eliquis, Carvedilol and Clotrimazole.
Deficiency is being cited according to California Code of Regulations, Title 22. Refer to LIC 809D.
Exit interview, appeal rights and a copy of this report was provided to Anna Rempel (Administrator).
|